Vinay Konaje
About Vinay Konaje
Vinay Konaje has 20 years in corporate governance. Holds Director role. Currently with 2 companies, including Navya Therapeutics Private Limited and Navya Biologicals Private Limited. Formerly with 3 companies, such as Shilpa Biologicals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Navya Therapeutics Private Limited
U21001KA2024PTC187774
|
Director | 24 Apr 2024 | 2024 | Active |
|
Navya Life Sciences Research Foundation
U73100KA2011NPL060638
|
Director | 30 Sep 2011 | 2011 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Shilpa Biologicals Private Limited
U24230KA2020PTC131456
|
Managing Director | 01 Jun 2020 | 2020 | Active |
Navya Biologicals Private Limited
U73200KA2006PTC039657
|
Director | 08 Jun 2006 | 2006 | Amalgamated |
|
Wanya Lifesciences Private Limited
U24290KA2022PTC166997
|
Director | 12 Oct 2022 | 2022 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vinay Konaje
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vinay Konaje
Vinay Konaje has 20 years in corporate governance. Holds Director role. Currently with 2 companies, including Navya Therapeutics Private Limited and Navya Biologicals Private Limited. Formerly with 3 companies, such as Shilpa Biologicals Private Limited. Engaged in General Business. Contributes to corporate operations.
Vinay Konaje is associated with 2 companies as Director.
Vinay Konaje has expertise in General Business.
Vinay Konaje has 20 years in corporate governance.